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Abstract
Background: There is growing evidence that the death receptor CD95 has a wider role in non-apoptotic functions.
In the brain, it may contribute to neural death and to the associated inflammatory reaction via a non-apoptotic
pathway. Brain injury triggers an inflammatory reaction in which the CD95/CD95L system acts principally through
peripheral cells recruited to the lesion. In cases of inflammation within the brain, with no blood–brain barrier
leakage, the role of the CD95/CD95L system is thus unclear. We investigated the possible role of CD95 and CD95L
in such conditions, by studying the relationships between glial cell activation, neuron death and CD95/CD95L
expression in the cerebellum of the Lurcher (Grid2Lc/+) mutant mouse, a model of cerebellar neurodegeneration.
Methods: Glial cells in slices of wild-type and Lurcher mouse cerebella were observed by light microscopy at
various ages overlapping periods of neuron loss and of pre- and post-neurodegeneration. Subcellular organization
was studied by electron microscopy. We assessed CD95 levels by western blotting, RT-PCR and glial cell cultures.
The levels of CD95L and IL-6 were studied by ELISA and a biological assay, respectively.
Results: In the Grid2Lc/+cerebellum, neuron loss triggers a typical, but abnormally persistent, inflammatory reaction.
We identified two phases of astrogliosis: an early burst of large glial cell activation, peaking at postnatal days 25 to
26, coinciding with peak cerebellar neuron loss, followed by a long period of slow decline indicating that the
strength of the glial reaction is modulated by neuron mortality rates. Comparisons of time-courses of glial cell
activation, cytokine production and neuron loss revealed that the number of surviving neurons decreased as CD95
increased. Thus, CD95 cannot be directly involved in neuron death, and its role must be limited to a contribution to
the inflammatory reaction. The upregulation of CD95 likely on astrocytes coincides with increases in the levels of
IL-6, a cytokine produced principally by astrocytes, and soluble CD95L.
Conclusions: These results suggest that CD95 and soluble CD95L contribute, via non-apoptotic signaling, to the
inflammatory reaction initiated early in neuron death within the Grid2Lc/+ cerebellum.
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Background
Central nervous system (CNS) inflammation may de-
velop in response to brain injury or in association with
neurodegeneration in human neurodegenerative dis-
eases, such as Parkinson’s, Huntington’s and Alzheimer’s
diseases. Inflammation resulting from trauma or ische-
mia reperfusion injury includes endothelial damage, the
release of proinflammatory mediators, changes in vascu-
lar permeability, infiltration with peripheral inflamma-
tory cells and the activation of microglia, the innate
immune cells of the brain, and astrocytes. It is marked
by the recruitment of peripheral blood cells and the
formation of a scar. CD95 (Fas, APO-1), which was
initially identified as a death receptor, and its cognate
ligand (CD95L, Fas-L) are both expressed in the brain.
They are thought to contribute to the inflammatory
reaction through non-apoptotic signaling, mediating
proinflammatory responses and triggering the recruit-
ment of peripheral macrophages and leukocytes to the
site of inflammation [1,2]. Recent data obtained by
Letellier et al. [3] for the spinal cord lesion model indi-
cate that the expression of CD95L on peripheral myeloid
cells plays a crucial role in the neural cell reaction at the
lesion. These authors demonstrated that peripheral cell
CD95L expression, which is upregulated by the lesion, is
required for the recruitment of peripheral myeloid cells
to the injured tissue and contributes to neural cell loss
by acting on peripheral myeloid cells, rather than via
direct CD95-induced apoptosis in CD95-bearing resi-
dent neural cells [3]. In neurodegenerative diseases, the
glial cell activation associated with neurodegeneration is
chronic. The inflammatory reaction is mild and features
an absence of leukocytes within the neural parenchyma
tissue; the possible occurrence of peripheral monocyte
infiltration remains a matter of debate [4-6]. Despite
these important differences between the two types of
inflammatory reaction, the CD95/CD95L system has
long been considered to play similar roles in the two
situations [1,7]. However, in the absence of infiltrating
peripheral cells, the contribution of the CD95/CD95L
system to neural cell reactions (neural degeneration
and the glial cell inflammatory reaction) remains
unclear. Natural mutant mice, such as the ataxic
Lurcher (Grid2Lc/+) mouse, which displays cerebellar
neurodegeneration, are valuable for investigations of
the role of the CD95/CD95L system in this context
making use of our extensive knowledge of cerebellar
neurodegeneration in this mutant [8].
Ataxia becomes clinically detectable in the Lurcher
mouse at about postnatal day 15 (P15). It results from
the progressive postnatal loss of cerebellar neurons
due to a mutation in the ∂2 glutamate receptor subunit
(GluR∂2) gene (Grid2). The Lurcher mutation is a
semi-dominant gain-of-function mutation involving a
base-pair change [9]. Within the cerebellum, GluR∂2 is
present specifically in Purkinje cells [10,11]. The expres-
sion of the mutated allele leads to a cell-autonomous
process of Purkinje cell degeneration occurring between
P7 and P30 [8]. As a result, 90% of the granule cells and
60 to 75% of the inferior olivary neurons die within the
first 3 months after birth, due to the loss of their target
[10,11]. The mechanisms by which Purkinje cells die
have remained elusive. Activated caspase-3, DNA frag-
mentation and autophagosomes in dying Purkinje cells
were thought to be the results of the activation of
various cell-death execution pathways [12-14]. Recent
in vitro and in vivo studies supported a necrosis mech-
anism caused by excitotoxicity and accompanied with
features of autophagy [15]. In the Grid2Lc/+ cerebellum,
this degenerative process takes place in an intact brain
with a fully functional blood–brain barrier (N Delhaye-
Bouchaud and J Mariani, unpublished data).
The glial reaction to neuron loss has remained largely
unexplored in the Grid2Lc/+ cerebellum. The presence
of reactive astrocytes and high IL-1ß concentrations
reported in previous studies suggest that an inflamma-
tory process occurs in the Grid2Lc/+ cerebellum [16,17].
In this study, we investigated the possible role of the
CD95/CD95L system in the mechanism of neuronal
death and in the inflammatory response, as an intrinsic
component of the glial reaction in the Grid2Lc/+ cerebel-
lum. We analyzed the relationship between the death of
cerebellar neurons and glial activation. Correlations
between glial cell activation and CD95 and CD95L ex-
pression on the one hand, and neurodegeneration events
occurring from birth into adulthood on the other, indi-
cate that the CD95/CD95L system is involved in the
inflammatory reaction, mostly through astrocytes.
Materials and methods
Animals
Heterozygous Grid2Lc/+ mutant mice (Lc/+) and the corre-
sponding wild-type strain, C57BL/6J X CBA (+/+), were
obtained by crossing Lc/+ males with +/+ females. Mutant
offspring were identified on the basis of ataxic behavior at
about P15, or by genotyping for younger animals, as previ-
ously described [12]. Animals were cared for and killed in
accordance with the guidelines of the French National
Ethics Committee for Life and Health Sciences.
Glial cell cultures
High-purity cultures of astrocytes and microglia were
prepared from mice from 5- and 1-day-old Lurcher
litters, respectively, as previously described [18].
Tissue collection
Cerebella and cerebral cortices were collected on ice in
an RPMI bath. The visible meninges and vessels were
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stripped away under a binocular microscope [17]. The
dissected tissue was then immediately frozen in liquid
nitrogen and stored at −80°C until use.
Immunoblotting
We homogenized 50 to 80 mg tissue in an Ultra-
Turrax homogenizer in lysis buffer containing 50 mM
Tris, 150 mM NaCl, 0.02% sodium azide, 1% Igepal
NP-40 and protease inhibitors (100 μg/ml 4-(2-
Aminoethyl) benzenesulfonyl fluoride hydrochloride
(AEBSF), 2 μg/ml iodoacetamide, 2 μg/ml leupeptin,
10 μg/ml soybean trypsin inhibitor (SBTI), 2 μg/ml
pepstatin, 1 μg/ml aprotinin). Lysates were then
centrifuged (10500 × g for 30 minutes) and the super-
natants were collected. Total protein concentrations
were determined on triplicate samples with the DC
Protein Assay from BIO-RAD, based on the Lowry
method. Samples were heated at 100°C for 1 minute in
loading buffer (125 mM Tris HCl, pH 6.8, 4% SDS, 0.025%
bromophenol blue, 20% glycerol, 10% 2-mercaptoethanol).
Proteins from 30 μg brain extract were separated by
SDS-PAGE in a 12% acrylamide gel and transferred to
Hybond-C super nitrocellulose membranes (Amersham,
Buckingham, UK). Membranes were blocked by incubation
with 5% non-fat milk powder and 5% normal goat serum in
TBS and incubated overnight at 4°C with 0.2 μg/ml rabbit
polyclonal M-20 anti-Fas antibody (Santa Cruz Biotechnol-
ogy) in TBS supplemented with 0.2% gelatin. The immuno-
complex was detected with peroxidase-conjugated anti-
rabbit secondary antibodies (Jackson ImmunoResearch
Laboratories, Inc.), with diaminobenzidine or a chemi-
luminescent substrate (Amersham Pharmacia Biotec.).
Immunohistochemistry
Mice were anesthetized by an intraperitoneal injection
of 3.5% chloral hydrate (0.1 ml/g body weight) and
transcardially perfused with buffer A (0.1 M cacodylate
buffer pH 7.2, containing 4% paraformaldehyde, 8%
saccharose and 5% dimethylsulfoxide). Brains were
postfixed by overnight incubation in buffer A at 4°C
and rinsed by incubation for 1 day with buffer A with-
out dimethylsulfoxide. A vibratome (LEICA VT 1000S)
was then used to cut one hemisphere into 30 μm sagit-
tal sections, which were placed in 0.2 M Tris-maleate
buffer (pH 7.2) supplemented with 8% saccharose.
Microglia were detected and stained by the nucleoside
diphosphatase histo-enzymological method, as previ-
ously described [19]. Briefly, sections were incubated
with 2 mM 5′-uridine-diphosphate in 80 mM Tris-
maleate buffer (pH 7.2) supplemented with 0.12% lead
citrate, 5 mM manganese chloride and 1% dimethyl
sulfoxide for 30 minutes at 37°C. The reaction product
was detected as a brown precipitate by incubating
sections in 2% ammonium sulfide. For glial fibrillary
acidic protein (GFAP) labeling, sections prepared as
described above were washed three times in TBS and
incubated in TBS supplemented with 1% Triton X-100
and 10% normal goat serum for 20 minutes. Rabbit
polyclonal anti-GFAP antibody (Sigma; 1/200 dilution
in TBS), and biotinylated goat anti-rabbit IgG antibody
(affinity-purified, from Vector Laboratories; 1/500 di-
lution), were applied to the sections, which were then
incubated overnight at 4°C and for 3 hours at room
temperature, respectively. Labeling was visualized with
the Vectastain ABC kit, using diaminobenzidine (Sigma) as
the chromogen.
Electron microscopy
Two Grid2Lc/+ mice were anesthetized with sodium pento-
barbital (15 mg/50 g body weight, Sanofi Diagnostic
Pasteur) and fixed by transcardial perfusion with 300 ml
1% paraformaldehyde and 1% glutaraldehyde in 0.1 M
phosphate buffer (pH 7.3). Sagittal sections (1 mm) of the
cerebellar vermis were cut with a vibratome and postfixed
by incubation for 1 hour in 1% osmium tetroxide. They
were then dehydraded by passage through a series of con-
centrations of ethanol and embedded in Araldite. Ultrathin
sections (60 nm thick) cut from blocks (1 mm3) sampled
from the vibratome sections were counterstained with
uranyl acetate and examined with a Hitachi 7500 transmis-
sion electron microscope.
Semiquantitative RT-PCR
Total RNA was isolated from frozen brain tissues with
the RNeasy Mini kit (Qiagen, Hilden, Germany) and
from cultured cells with Trizol reagent. RNA concentra-
tion and purity were determined with a Nanodrop
ND-1000 spectrophotometer. The reverse transcription
reaction was performed with a Reverse Transcription
System kit (Promega), with avian myeloblastosis virus
transcriptase and oligo(dT)15 primers, according to the
manufacturer’s instructions. The first-strand cDNA was
amplified by PCR in a Perkin Elmer Thermal Cycler,
with Taq polymerase and the primers for GFAP (sense
primer TTC CTG TAC AGA CTT TCT CC and anti-
sense primer CCC TTC AGG ACT GCC TTA GT); Fas
(sense primer CAT CTC CGA GAT TTT AAA GC and
antisense primer GTT TCC TGC AGT TTG TAT TGC
T) and hypoxanthine-guanine phosphoribosyltransferase
(HPRT) (sense primer CCT GCT GGA TTA CAT TAA
AGC ACT G and antisense primer GTC AAG GGC
ATA TCC AAC AAC AAA C). We used appropriate
concentrations of cDNA to ensure that PCR was carried
out in non-saturated conditions. Amplification products
were visualized by electrophoresis in a 2% agarose
gel containing ethidium bromide (0.6 mg/ml), and
quantified by densitometry with Densylab software
(Microvision Instruments, Evry, France). Values were
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normalized with respect to the amplicon for the HPRT
housekeeping gene. A stimulation index (SI) was calcu-
lated for the kinetic study. SI is defined as the normal-
ized CD95 mRNA level for stimulated cells from which
we subtracted the normalized CD95 mRNA level for
unstimulated cells, before dividing the result by the
normalized CD95 mRNA level for unstimulated cells.
Determination of cytokine levels
IL-6 activity and CD95L concentration were determined
on tissue extracts prepared as previously described [17].
Briefly, frozen tissues were rapidly weighed, dissociated
with a Dounce Potter homogenizer on ice with five parts
by weight of RPMI containing antiproteases (10 mM
amino-n-caproic acid, 0.5 mM benzamidine, 1 mM
ethylenediaminetetraacetic acid (EDTA) and 20 μM
AEBSF for CD95L and only EDTA and AEBSF for IL-6
). The resulting homogenate was centrifuged for 30 mi-
nutes at 13400 × g at 4°C. Supernatants were collected,
and small aliquots were immediately frozen at −20°C
until use. Total protein concentrations were deter-
mined as described above for immunoblotting. Two
cerebella from different animals were used to prepare a
single extract. Each sample was analyzed in duplicate.
IL-6 activity was determined in a biological assay with
the IL-6-dependent B-cell hybridoma B9. B9 cells (5 ×
10 3 cells/well, in 100 μl) were plated in 96-well micro-
titer plates, and 100 μl of a serial dilution of extract
and murine IL-6 as a standard were added. The plates
were incubated for 72 hours at 37°C in a humidified
chamber containing 5% CO2-95% air. B9 cell growth
was then assessed in an MTT assay. We incubated 0.5
mg/ml MTT with cells for 3.5 hours in a culture incu-
bator. Insoluble purple formazan salts were solubilized
with 150 μl isopropanol plus 0.1 M HCl and absorb-
ance was determined at 560 nm. Fas-L concentra-
tions were measured in a sandwich ELISA with the
Quantikine M kit from R&D Systems, in accordance
with the manufacturer’s instructions. Experiments
were repeated two or three times.
Statistical analysis
Group difference was established by using the non-
parametric Mann Whitney test or with a one-way
analysis of variance with de Scheffé multiple compari-
son test for multiple group comparison. Homogeneity
of the variance was assessed using F-test. Statistical
analyses were carried out using StatView software
(Abacus Concept).
Results
Early neurodegeneration in the Grid2Lc/+ cerebellum is
associated with the persistent activation of glial cells.
Grid2Lc/+ cerebellar neurons die between P7 and P90,
with large-scale degeneration occurring between P17
and P25 [11]. We studied the time course of the glial
cell reaction to neuron loss by following glial morpho-
logical changes from P5 to adulthood by GFAP
immunolabeling for astrocytes and the histoenzymatic
nucleoside diphosphatase method for microglia. Cere-
bella from P5, P13, P21 and P150 mice were studied. At
P5, round or ameboid microglial cells were present in
the cerebellar white matter of both wild-type and mu-
tant mice (data not shown). These microglia were of the
macrophage type and were subsequently replaced by
microglia displaying signs of activation, with an enlarged
cell body and short thick processes, in the Grid2Lc/+
cerebellum, and by non-activated microglia in the wild
type (see Figures 1A and 1B, respectively). At P13, acti-
vated microglia were detected either as isolated cells or
in sparse clusters, indicating the occurrence of a micro-
glial activation process that began before this time point.
Clusters were first observed in the vicinity of Purkinje
cell bodies at about P13. They were later found through-
out the cerebellum of Grid2Lc/+ adult mice, particularly
in the vicinity of blood vessels (Figure 1D). In the adult
wild-type cerebellum (Figure 1C) and in the other
brain structures, such as the brainstem, the microglia
remained non-activated (data not shown).
Paralleling the microglial reaction, astrocytes displayed
changes in morphology from P13 and P21 into adult-
hood. In the P21 degenerating Grid2Lc/+ cerebellum,
fibers of Bergmann glia were shorter and less regularly
spaced than in the cerebella of control littermates (data
not shown). The granular layer was invaded by numer-
ous strongly stained astrocytes, which persisted during
adulthood (Figure 2B). Electron microscopy showed that
all surviving neuronal processes - a few parallel fibers,
basket and stellate interneurons in the molecular layer
and rare glomeruli in the internal granular layer - were
rolled up into hyperdeveloped, superimposed astrocytic
processes extending throughout the atrophied cerebellar
cortex of the Grid2Lc/+ mutants (Figures 3A,B).
Long-term astrocyte activation is preceded by acute gfap
gene activation
GFAP upregulation is a hallmark of astrocyte activation.
We investigated the transcriptional regulation of GFAP
in the Grid2Lc/+ cerebellum by analyzing gfap mRNA
levels at various time points in the Grid2Lc/+ and wild-
type cerebellum (Figure 4). In the wild-type cerebellum,
gfap mRNA levels decreased from P5 to P18 and
remained stable and low throughout the rest of the study
period (data not shown). In the Grid2Lc/+ cerebellum,
gfap mRNA levels increased strongly between P22 and
P25, peaking sharply at a level 93 times higher than that
in the wild type. In parallel to the age-related neuron
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survival, according to the estimates reported by Caddy
and Biscoe for the Lurcher cerebellar neuron population
[11], a burst of gfap mRNA production was found to
occur at the end of a period of extensive neuron
(Purkinje and granule cell) loss. From P36 until P110
gfap mRNA levels remained high. They stabilized in
adult Grid2Lc/+ cerebellum at a level 10 times that in
wild-type cerebellum.
Increases in CD95 expression reflect astroglial cell
activation
CD95 is expressed principally on neurons and, to a
lesser extent, on glial cells in the adult brain [2]. Its ex-
pression is upregulated in pathological conditions. We
investigated the contribution of CD95 to Grid2Lc/+
cerebellar degeneration by studying CD95 expression in
the cerebellum of Grid2Lc/+ and wild-type mice by west-
ern blot analyses of crude cerebellar extracts (Figure 5).
The anti-CD95 antibody used cross-reacts with un-
defined proteins, as previously described [20]. We thus
included a negative control in our study: thymic extracts
from lpr mice, which have only very low levels of CD95
[21]. CD95 was identified as a 52 kDa band. A 46 kDa
band was consistently detected in all tested brain tissue
extracts and may correspond to a non-glycosylated form
of CD95 (Figure 5A) [20]. We evaluated CD95 expres-
sion in the Grid2Lc/+ mutant and wild-type littermate
cerebella at P22 and P52. P22 corresponds to a period of
massive neuron loss. One month later, at P52, the neur-
onal death process is coming to an end [11]. CD95 was
significantly more strongly expressed in the Grid2Lc/+
Figure 1 Microglial activation in the Grid2Lc/+ cerebellum. Sagittal sections of wild-type (A,C) and Grid2Lc/+ (B,D) cerebella from 21-day-old
(A,B) and adult (C,D) mice were stained by the dinucleoside diphosphatase technique. Microglia (arrow) and blood vessels (arrow-head) are
labeled. (B and D) Isolated activated microglial cells with enlarged cell bodies and thick processes are present specifically in the cerebellum of
21-day-old Grid2Lc/+ mice (B). In adult (D) mice, microglia are mostly organized into clusters (open arrow). Scale bars: A and B, 30 μm; C and D,
100 μm.
Figure 2 Astrocyte activation in the Grid2Lc/+ cerebellum. Sagittal sections of wild-type (A) and Grid2Lc/+ (B) cerebella from 21-day-old mice
were immunolabeled for glial fibrillary acidic protein. Strongly stained astrocytes have colonized the degenerating granular layer of the Grid2Lc/+
cerebellum and surround blood vessels with their enlarged processes (arrows). Scale bars: 20 μm.
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than in the wild-type cerebellum, and its expression in-
creased steadily from P22 to P52 (Figure 5B).
We characterized CD95 upregulation in the Grid2Lc/+
cerebellum further, by studying CD95 transcripts from
P5 to P110. In the Grid2Lc/+ cerebellum, transcripts
levels were similar to those in the wild type until P18.
From P18 onwards, they increased over a period of 8
weeks, eventually reaching a plateau at a level 10 times
that in the wild type (Figure 5C). CD95 mRNA levels
were still high in 16-month-old Grid2Lc/+ mice (data not
shown).
Thus, the increase in CD95 expression was due to an
increase in the number of CD95 transcripts, indicating
the involvement of a transcriptional mechanism.
We investigated the cellular distribution of CD95 by
carrying out immunohistochemistry studies in brain
slices with several anti-CD95 antibodies. Studies of
CD95-deficient mice, used as a negative control, showed
that none of the antibodies tested, including those used
for western blotting, was entirely specific for CD95 in
brain slices, as previously reported [22]. Thus, we looked
for CD95 transcripts in cultures highly enriched in wild-
type and Grid2Lc/+ astrocytes and microglia (Figure 6).
No difference was found between wild-type and mutant
cells. Non-stimulated resting astrocytes expressed CD95,
whereas microglia did not. CD95 transcript levels were
upregulated by proinflammatory treatment in astrocytes,
but not in microglia, in which neither lipopolysaccharide
(LPS) nor proinflammatory cytokines (data not shown)
induced CD95 expression (Figure 6A). In cultured astro-
cytes, high levels of CD95 were detected after 40 mi-
nutes of stimulation with proinflammatory cytokines,
these levels increasing for up to 2 hours (Figure 6B).
Upregulation of soluble CD95L and inflammatory
cytokines
In normal brain, inflammatory cytokines are either ab-
sent or are produced in quantities only just exceeding
the detection threshold. These molecules are induced or
Figure 3 Astrogliosis in the adult Grid2Lc/+ cerebellum.
Representative electron microscopy views of the molecular layer (A)
and of the internal granular layer (B). In the molecular layer, a few
surviving parallel fibers (pf) are wrapped in abnormally abundant,
superimposed astrocytic processes (asterisk); G, glial cell soma with
electrolucent cytoplasm; n, nucleus. In the internal granular layer,
abundant astrocytic processes are stacked around a cerebellar
glomerulus made of a mossy fiber-like terminal (mf) forming
asymmetric synapses (arrowheads) on a few granule cell dendrites
(gc), which receive inputs from Golgi neuron terminals (go) at
symmetric synapses (arrows). Bar: 500 nm.
Figure 4 Time course of gfap mRNA levels in the Grid2Lc/+ (Lc)
cerebellum from postnatal day 5 (P5) to P110. Gfap mRNA is
present in large amounts from P22 to P120. The gfap mRNA is
produced in a large burst coinciding with the end of the episode of
massive neuron degeneration. The results are expressed as the ratio
of Grid2Lc/+ gfap mRNA to wild-type gfap mRNA, and the means ±
SEM of four to six paired age-matched Grid2Lc/+ and wild-type mice
are shown. Age-related survival of neurons (shaded in gray),
including Purkinje and granule cells, was determined from the
estimates of Caddy and Biscoe [11]. Survival is expressed as a
percentage of the number of cerebellar neurons on P4.
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upregulated during brain inflammation featuring glial
cell activation. We previously showed that levels of the
proinflammatory cytokine IL-1ß were higher in 4-month
-old Grid2Lc/+ mice than in the wild type [17]. We inves-
tigated the involvement of CD95L in the glial reaction in
Grid2Lc/+ cerebellum by studying soluble CD95L levels
in wild-type and mutant mouse cerebellum. Determina-
tions were carried out at two time points - during the
period of intense degeneration and much later, at P21
and P150, respectively (Figure 7A). CD95L was detected
in the cerebellum of young wild-type mice, but it in-
creased in abundance with age. CD95L levels in the
Grid2Lc/+ cerebellum were higher than those in the wild
type at both ages. In the cerebral cortex of mutant and
wild-type mice, CD95L levels were in the range of values
found for the P150 wild-type cerebellum (data not
shown). We also investigated changes in the amount of
IL-6, an inflammatory cytokine produced mostly by as-
trocytes and, to a lesser extent, microglia, during brain
inflammation. We determined IL-6 levels during and
after neurodegeneration, from P5 to P130 (Figure 7B).
IL-6 was undetectable during the first 3 weeks after birth
in both wild-type and Grid2Lc/+ cerebella. From P50 to
adulthood, IL-6 was present at stable, low levels in the
cerebellum of the wild-type mice but at levels three
times higher in Grid2Lc/+ mice.
Discussion
The CD95 receptor and its ligand, CD95L, are thought
to contribute to brain neural death and inflammation
processes through non-apoptotic signaling. In this study,
we investigated the role of the CD95/CD95L system in
the cerebellum of the Grid2Lc/+ mutant mouse, a model
of naturally occurring brain parenchyma neurode-
generation without damage to the blood–brain barrier.
We focused on the associated inflammatory reaction.
We studied glial cell activation and CD95 expression be-
fore, during and after cerebellar neuron loss. Levels of
CD95 and its ligand were high in mutant mice, and we
observed a protracted inflammatory reaction triggered
by the early onset of cerebellar neuron death. The corre-
lations identified in studies of the time courses of CD95
expression, neuron survival and astrocyte activation
indicated that CD95 was expressed on glial cells, but not
on neurons, and might therefore contribute exclusively
to the inflammatory process.
The time course and mechanisms of death of the vari-
ous types of neurons in mutant mice have been widely
studied and are well understood [8]. In this study, we
studied the glial reaction to neuron loss. Analyses of the
morphological and biochemical criteria for glial cell
activation showed that astrocytes and microglia were ac-
tivated in a process characterized by an early onset and
a burst of activation between P22 and P25, coinciding
Figure 5 CD95 expression in the Grid2Lc/+ cerebellum. (A)
Western blot analysis of the CD95 protein in crude extracts of
cerebral cortex and cerebellum from Grid2Lc/+ (Lc) mutant and wild-
type (wt) mice. Thymus extracts from lpr and wt mice were used as
negative and positive controls, respectively. (B) CD95 western blot
analysis at two time points - postnatal day 22 (P22) and P52 - in wt
and Lc cerebella, and relative densitometric quantification of the 52
kDa band, expressed as a percentage of a reference protein sample.
Values are the means ± SEM of four independent determinations
(one-way analysis of variance followed by de Sheffé multiple
comparison test, *P <0.05, **P <0.01). (C) Time course of CD95
mRNA production in the cerebellum of Lc and wt mice from P5 to
adulthood. The results are expressed as the ratio of the Lc CD95
mRNA to wt CD95 mRNA, and the means ± SEM of four paired
age-matched Lc and wt mice are shown. Note that CD95 levels
begin to increase at the end of the episode of massive neuron
degeneration (shaded in gray; see Figure 4).
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with peak levels of neuron cell death. From P7 to P30,
90% of the Purkinje cells and granular neurons
disappeared from the Grid2Lc/+ cerebellum. Purkinje
cells genetically committed to death display morpho-
logical and physiological alterations that can be
detected as early as P6 and they die between P10 and
P30 [11]. Our findings, consistent with the kinetics of
Purkinje cell and granular neuron degeneration, show
that microglia are activated after P5 and before P13
and that not all microglial cells are reactive at P13,
probably due to the gradual loss of cerebellar neurons.
Furthermore, the clusters of microglia found in a few
areas of the Purkinje cell layer were consistent with the
“holes” lacking Purkinje cells in this layer described in
P12 Grid2Lc/+ by Dumesnil-Bousez and Sotelo [23].
Clustered microglia are probably of the macrophage
type, playing a role in the removal of dead cells [24,25].
Complete microglial activation throughout the cerebel-
lum occurs during the period of mass neuron death
between P17 and P25 [11]. Astrocyte activation paral-
lels microglial activation, but with a small time lag, in
the stereotypical glial reaction to brain injury. Micro-
glial cells are fully activated at about P25 to P26,
whereas astrocytes are only just beginning to be acti-
vated at this time point, as shown by the upregulation
of GFAP. Astrocyte activation begins with a huge burst
of gfap transcription (resulting in transcript levels 93
times higher than those in the wild type) coinciding
with a period of mass neuron death in the Grid2Lc/+
cerebellum. In the adult Grid2Lc/+ cerebellum, gfap
mRNA levels remain 10 times higher than those in the
wild type, and microglial clusters may persist for up
to 5 months. Electron microscopy revealed that,
throughout the highly disturbed cytoarchitecture of
the Grid2Lc/+ cerebellum, astrocytes ensheathed the
surviving neurons - basket, stellate and Golgi cells
[11] - in a large number of stacked astrocytic processes
forming a cocoon-like structure.
The Grid2Lc/+ glial response resembles experimental
models of acute neuronal degeneration, in which dead
neurons are rapidly removed by phagocytic microglia,
and neuron-depleted areas are filled with astrocytes,
leading to the formation of a scar [25,26]. Nevertheless,
it differs from these models in the persistence of acti-
vated microglial cells long after the neurodegenerative
event. For example, in the mouse model of kainic acid-
induced hippocampal neuronal death, for doses of kainic
acid destroying all pyramidal cells in the injected hippo-
campus without affecting non-neuronal cells, the num-
ber of microglia with a quiescent cell morphology
returns to normal after about 3 months [27]. Thus, the
Grid2Lc/+ microglial reaction triggered by early neuron
loss seems to decline very slowly, taking a particularly
long time to come to an end.
In the Grid2Lc/+ cerebellum, the onset of the neuron
loss takes place early after birth, overlapping a period
known to have specific inflammatory properties. Lawson
and Perry [28] have shown that, during postnatal devel-
opment, there is a window of susceptibility to induce a
classical inflammatory response, resembling that seen in
non-CNS tissues. They showed that, in contrast to
adult mice, 7-day-old mice injected with LPS in the
parenchyme develop a vigorous inflammatory response
with prolific neutrophil recruitment and a brisk mono-
nuclear phagocyte response. In contrast to the model of
Lawson and Perry, Grid2Lc/+ glial cell activation occurs
Figure 6 CD95 mRNA levels in cultured astrocytes. (A) Cultures highly enriched in astrocytes and microglia were stimulated with a mixture of
IL-1β (20 ng/ml) and TNFα (50 ng/ml) for 2 hours (gray bars). Open bars, unstimulated cell culture. (B) Kinetic study of CD95 mRNA production in
stimulated astrocyte cultures. The values shown are the means ± SEM of four different glial cell cultures (Mann Whitney test, **P <0.01).
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without leakage of the blood–brain barrier and periph-
eral cell intrusion (N Delhaye-Bouchaud and J Mariani,
unpublished data). Thus, the glial activation intensity
may be related to the age-related properties of the in-
flammatory response while the absence of infiltrating
peripheral cells, known to contribute to the healing
mechanisms [29], may be responsible for the persistence
of the glial reaction. Taken together, this may give an un-
usual dynamic to the glial reaction in the Grid2Lc/+
cerebellum.
The cellular origin of CD95 in the brain has been the
subject of lively debate. Neurons, astrocytes and oligo-
dendrocytes have all been shown to express CD95, and
it is now thought that neurons are the strongest
expressers of CD95 in the normal adult brain, whereas
CD95 expression is detected on glial cells in patho-
logical conditions. CD95L is present in the body as a
membrane-bound protein mediating apoptotic signal-
ing, or as a metalloprotease-cleaved soluble form. In
the brain, CD95L has been reported to be constitu-
tively expressed on neurons and astrocytes and
upregulated by inflammation [2,30].
In the Grid2Lc/+ cerebellum, increases in the levels of
both GFAP and CD95, and decreases in neuron survival
occur simultaneously, suggesting that the CD95 synthe-
sized de novo originates from astrocytes. Unfortunately,
we were unable to show that CD95 was located on as-
trocytes by immunohistochemical methods, due to the
known lack of specificity of antibodies directed against
the mouse protein [22]. However, increase in CD95
levels in response to stimulation on cultured astrocytes
[31,32] but not on microglia suggests that the newly syn-
thesized CD95 is of astrocytic origin. The soluble form
of CD95L (sCD95L) is also abnormally expressed in the
Grid2Lc/+ cerebellum. Peripheral cells, such as T cells or
cells of the monocyte lineage, cannot be held responsible
for the production of CD95L in this context, because
peripheral immune cells are not recruited to the brain
during cerebellar degeneration in Grid2Lc/+ mice (N
Delhaye-Bouchaud and J Mariani, unpublished data).
However, the CD95L producing cells within the Grid2Lc/+
cerebellum remain to be identified.
In the Grid2Lc/+ cerebellar inflammatory reaction,
CD95L might be involved in several of the mechanisms
of reactive gliosis. Recently, sCD95L has been implicated
in cell migration via a non-apoptotic pathway. The
underlying mechanism involves the formation of a
specific signaling complex containing CD95 [30]. Cell
migration is an important process in the cascade of
events occurring during the inflammatory reaction, and
is a feature of microglial cells in the CNS. Several mech-
anisms involving different microglial attractants have
been described [33] and it is not possible to rule out the
possibility that sCD95L belongs to the microglial motil-
ity machinery. However, sCD95L might play a role in
the motility of the astrocytes, which grow and fill the
spaces vacated by the lost neurons. Less speculative is
the role of CD95 activation in the induction or
upregulation of inflammatory mediators, such as IL-1,
IL-6, IL-8 and cell surface integrins [34]. We found that
IL-6 concentration increased with glial cell activation. In
a previous study, abnormally high basal levels of IL-1ß
were detected in adult Grid2Lc/+ cerebellum [17]. These
two cytokines play an essential role in the inflammatory
Figure 7 CD95L and IL-6 levels in the cerebellum of Grid2Lc/+.
(A) Representative experiment from the CD95L study. CD95L
concentrations were determined in crude cerebellum extracts from
Grid2Lc/+ (open bars) and wild-type (black bars) mice, by ELISA. (B)
Representative time-course study of IL-6 levels in the cerebellum of
Grid2Lc/+ (open diamonds) and wild-type (black diamonds) mice.
Levels were determined in a biological activity assay. Note that IL-6
levels begin to increase at the end of the period of massive neuron
degeneration (shaded in gray; see Figure 4). The mean values for
four determinations are shown, with range error bars.
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cascade. IL-6, which is mostly produced by astrocytes
during brain inflammation, triggers astrocyte prolifera-
tion and is believed to be involved in astrogliosis and the
activation of microglia [31,35]. Microglia are the princi-
pal inducible source of IL-1ß, a strong inducer of astro-
cyte proliferation [36]. Thus, within the adult Grid2Lc/+
cerebellum, reactive gliosis may self-perpetuate for some
time through the cytokine and chemokine network,
including the CD95/CD95L system, in the absence of
infiltrating peripheral immune cells. Such peripheral
immune cells play a key role in the repair cascade
resulting in the healing of brain wound [29].
In conclusion, our findings support the involvement of
the CD95/CD95L system in the glial reaction triggered
by neuron death, through non-apoptotic signaling in the
neurodegenerative cerebellum of Grid2Lc/+ mutant mice.
The persistence of microglial activation in this model is
consistent with the misregulation of molecular mecha-
nisms responsible for the termination of glial activation,
in which the role of the CD95/CD95L system remains to
be determined.
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